Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Gyre Therapeutics Inc (NASDAQ: GYRE) closed the day trading at $11.70 down -3.23% from the previous closing price of $12.09. In other words, the price has decreased by -$3.23 from its previous closing price. On the day, 79805.0 shares were traded. GYRE stock price reached its highest trading level at $12.55 during the session, while it also had its lowest trading level at $11.5.
Ratios:
For a better understanding of GYRE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.29 and its Current Ratio is at 3.72. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On February 10, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $15.
On May 21, 2020, Raymond James started tracking the stock assigning a Outperform rating and target price of $20.Raymond James initiated its Outperform rating on May 21, 2020, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 28 ’24 when USMAN NASSIM sold 3,452 shares for $12.00 per share. The transaction valued at 41,438 led to the insider holds 1,636 shares of the business.
USMAN NASSIM sold 20,000 shares of GYRE for $282,577 on May 01 ’24. The Director now owns 1,636 shares after completing the transaction at $14.13 per share. On Apr 01 ’24, another insider, USMAN NASSIM, who serves as the Director of the company, sold 20,000 shares for $16.15 each. As a result, the insider received 323,000 and left with 1,636 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GYRE now has a Market Capitalization of 1004120960 and an Enterprise Value of 1249466240. Its current Enterprise Value per Revenue stands at 11.197 whereas that against EBITDA is 62.221.
Stock Price History:
Over the past 52 weeks, GYRE has reached a high of $30.40, while it has fallen to a 52-week low of $8.26. The 50-Day Moving Average of the stock is -13.89%, while the 200-Day Moving Average is calculated to be -17.40%.
Shares Statistics:
Over the past 3-months, GYRE traded about 57.75K shares per day on average, while over the past 10 days, GYRE traded about 86920 shares per day. A total of 76.60M shares are outstanding, with a floating share count of 23.65M. Insiders hold about 74.71% of the company’s shares, while institutions hold 1.72% stake in the company. Shares short for GYRE as of 1730332800 were 376581 with a Short Ratio of 6.96, compared to 1727654400 on 457298. Therefore, it implies a Short% of Shares Outstanding of 376581 and a Short% of Float of 2.6300002.
